Phase 2 Study of Oral AB1010 in Non Pre-treated, Inoperable Patients With Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST).

Trial Profile

Phase 2 Study of Oral AB1010 in Non Pre-treated, Inoperable Patients With Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST).

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2012

At a glance

  • Drugs Masitinib (Primary)
  • Indications Gastrointestinal stromal tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Sep 2012 Planned End Date changed from 1 Jan 2011 to 1 Jun 2014 as reported by ClinicalTrials.gov.
    • 05 Jun 2012 Five-year follow-up results have been presented at ASCO-2012 according to an AB Science media release. Results were also reported in the media release.
    • 30 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top